Objective:The aim of this study was to investigate the efficacy and safety of bladder flap ureteroplasty (psoas hitch) in the treatment of lower ureteral injuries and strictures.Methods:19 patients with lower ureteral injuries and strictures scheduled for a bladder flap ureteroplasty (psoas hitch) in our hospital from January 2020 to January 2021 were recruited. The outcome measures included treatment efficacy and safety.Results:The operative time, intraoperative bleeding, catheter extubation time, hospital stay, extubation time of ureteral stent, and follow-up time were (125.36 ± 15.38) min, (75.37 ± 11.09) ml, (7.25 ± 1.04) d, (8.76 ± 1.11) d, (46.34 ± 7.66) d, and(19.27 ± 1.27) months, respectively. No serious perioperative adverse reactions were observed, and all the symptoms of patients were relieved.Conclusion:Bladder flap ureteroplasty (psoas hitch) is safe and effective for the treatment of lower ureteral injuries, with advantages such as less intraoperative bleeding and trauma and rapid recovery, so it is worthy of promotion. This was a retrospective study supervised by the Ethics Committee of Hebei Yanda Hospital.This trial is registered with no. hebYD076.

The purpose of this study was to explore the efficacy and safety of transurethral resection of bladder tumor (TURBT) in the treatment of superficial bladder cancer (SBC). In this retrospective study, we included 103 patients with SBC who were admitted to the Hebei Yanda Hospital from March 2015 to May 2019. Among them, 53 patients were treated by TURBT and assigned to the research group. The rest, 50 patients, were treated by partial cystectomy (PC) and were included in the control group. The two groups were compared in terms of curative efficacy, complications, operation-related indexes, 2-year recurrence and survival, quality of life, and serum tumor markers. The operation-related indexes mainly included intraoperative blood loss, the time of operation, bladder flushing, catheter indwelling, and hospitalization. The quality of life of patients was assessed by the 36-Item Short-Form Health Survey (SF-36). The data revealed that compared with the control group, the overall response rate and the scores of various dimensions of the SF-36 were significantly higher in the research group. The complication rate, surgical indicators, and 2-year recurrence were significantly lower in the research group, with a better survival. Serum levels of tumor marker cancer antigen 125 (CA125), carcinoembryonic antigen (CEA), and neuron specific enolase (NSE) in the research group were significantly lower than those in the control group after treatment. TURBT is effective and safe in the treatment of patients with SBC.

目的 超选择肾动脉弹簧圈栓塞术治疗经皮肾镜碎石取石术(PCNL)后严重出血的疗效.方法 收集2017年1月至2020年12月河北燕达医院收治的PCNL后严重出血行超选择肾动脉弹簧圈栓塞术治疗39例患者临床资料.统计PCNL后患者肾动脉出血情况;术后不良反应(恶心、呕吐、发热、腰痛);栓塞术成功率和术后肾功能情况.结果 肾动脉上支出血率17.95％、中支出血率51.28％、下支出血率30.77％;迟发性出血率53.85％、持续性出血率46.15％;输血率58.97％.39例患者的栓塞成功率94.87％;术后不良反应中,恶心发生率17.95％,呕吐发生率12.82％,发热发生率25.64％,腰疼发生率43.59％.术后的肾小球滤过率高于术前,血清尿素氮和血清肌酐低于术前,差异有统计学意义(P<0.05).结论 PCNL术后严重出血患者应尽快行数字减影血管造影(DSA)明确诊断后进行栓塞治疗,DSA和超选择肾动脉弹簧圈栓塞术可作为PCNL大出血首选的检查及治疗方法,超选择肾动脉弹簧圈栓塞术是安全有效的治疗方式,值得推广.

目的:分析经尿道钬激光前列腺剜除术在治疗前列腺增生症中的临床优势.方法:选择我院2019年6月-2020年11月前列腺增生症患者共60例,数字表随机分2组,每组30例,对照组的患者给予常规手术治疗,观察组采取经尿道钬激光前列腺剜除术.比较两组失血量、住院的总时间、治疗前后患者国际前列腺症状积分、生活质量评分以及尿流最大水平、并发症发生率.结果:观察组失血量、住院的总时间低于对照组,治疗后两组患者国际前列腺症状积分、生活质量评分以及尿流最大水平均优于治疗前,观察组并发症发生率低于对照组,P<0.05.结论:经尿道钬激光前列腺剜除术对于前列腺增生症的治疗效果确切,可减少并发症和创伤,缩短康复时间,更好改善患者生存质量,值得推广.